| ABCA1 | ATP binding cassette transporter A1 |
| ACEi | Angiotensin-converting-enzyme inhibitors |
| AGEs | Advanced glycation end-products |
| Akt | Protein kinase B |
| ApoE | Apolipoprotein E |
| AP-1 | Activator protein-1 |
| ARBs | Angiotensin Receptor Blockers |
| ASK1 | Apoptosis signal-regulating kinase 1 |
| BMP-7 | Bone morphogenetic protein 7 |
| BTBR | Black and tan brachyuric |
| BUN | Blood urea nitrogen |
| CASP1 | Caspase-1 |
| CCL11 | Chemokine-CC motif ligand 11 |
| CCL2 | Chemokine-CC motif ligand 2 |
| CCL5 | Chemokine-CC motif ligand 5 |
| CCR2 | C-C chemokine receptor 2 |
| CCR5 | C-C chemokine receptor 5 |
| CD206/MRC1 | Mannose receptor |
| CD4+ | Cluster of differentiation 4+ |
| CD74 | Cluster of differentiation 74 |
| CD8+ | Cluster of differentiation 8+ |
| CKD | Chronic kidney disease |
| Col IV | Collagen IV |
| CVD | Cardiovascular Disease |
| CX3CL1 | Fractalkine |
| CX3CR1 | Fractalkine receptor |
| CXCL1 | Chemokine (C-X-C motif) ligand 1 |
| CXCL10 | Chemokine (C-X-C motif) ligand 10 |
| CXCL12 | Chemokine (C-X-C motif) ligand 12 |
| CXCL16 | Chemokine (C-X-C motif) ligand 16 |
| CXCL5 | Chemokine (C-X-C motif) ligand 5 |
| CXCL8 | Chemokine (C-X-C motif) ligand 8 |
| CXCL9 | Chemokine (C-X-C motif) ligand 9 |
| CXCR4 | C-X-C chemokine receptor type 4 |
| db/db | Diabetic/diabetic |
| DCs | Dendritic cells |
| DN | Diabetic nephropathy |
| DNA | Deoxyribonucleic acid |
| DPP4i | Dipeptidyl peptidase-4 inhibitors |
| eGFR | Estimated glomerular filtration rate |
| EMT | Epithelial to mesenchymal transition |
| EndMT | Endothelial to mesenchymal transition |
| ERK 1/2 | Extracellular Signal-Regulated Kinase 1/2 |
| ESRD | End-stage renal disease |
| FGF1 | Acidic fibroblast growth factor |
| GBM | Glomerular basement membrane |
| GLP-1 | Glucagon-Like Peptide 1 |
| GLP-1 RA | GLP-1 receptor agonists |
| GSK-3β | Glycogen synthase kinase 3β |
| HbA1c | Hemoglobin A1c |
| HK-2 | Human kidney 2 cells |
| HO-1 | Heme Oxygenase 1 |
| ICAM-1 | Intercellular adhesion molecule-1 |
| IFN-γ | Interferon-γ |
| IgG | Immunoglobulin G |
| IgM | ImmunoglobulinM |
| IKKα/β/γ | IκB kinase α/β/γ |
| IL-10 | Interleukin-10 |
| IL-17A/F | Interleukin-17A/F |
| IL-18 | Interleukin-18 |
| IL-1β | Interleukin-1β |
| IL-2 | Interleukin-2 |
| IL-20 | Interleukin-20 |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| IP-10 | Interferon-inducible protein 10 |
| JAK | Janus Kinase/ Just Another Kinase |
| KIR | Kinase inhibitory region |
| KRIS | Risk inflammatory signature |
| LDL | Low Density Lipoprotein |
| Ly6C | Lymphocyte antigen 6C |
| mAb | Monoclonal Antibody |
| MAP3K5 | Mitogen-activated protein kinase 5 |
| MAPK | Mitogen-Activated Protein Kinase |
| MDA | Malondialdehyde |
| MEK | Mitogen-activated protein kinase kinase |
| MIF | Macrophage migration inhibitory factor |
| MIP-1 | Macrophage Inflammatory Protein-1 |
| MMP | Matrix metalloproteinase |
| mTOR | Mammalian target of rapamycin |
| NADPH | Nicotinamide adenine dinucleotide phosphate hydrogen |
| NBD | Nucleotide-binding domain |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLR | Nucleotide-binding oligomerization domain (NOD)-like receptors |
| NLRP | Pyrin domain-containing protein |
| NOD1 | Nucleotide-binding oligomerization domain-containing protein 1 |
| NOD2 | Nucleotide-binding oligomerization domain-containing protein 2 |
| NOX-4 | NADPH oxidase 4 |
| Nrf2 | Nuclear factor (erythroid-derived 2)-like 2 |
| Ob | obese |
| P38/MAPK | p38 mitogen-activated protein kinase |
| p53 | Cellular tumor antigen p53 |
| PDGF | Platelet derived growth factor |
| PI3K | Phosphatidylinositol 3-kinase |
| PKC | Protein kinase C |
| PPAR-γ | Peroxisome proliferator-activated receptor-γ |
| PTEN | Phosphatase and tensin homolog |
| PTX3 | Pentraxin 3 |
| RAAS | Renin–-angiotensin–-aldosterone system |
| ROS | Reactive Oxygen Species |
| SGLT2 | Sodium-glucose cotransporter-2 |
| SGLT2i | SGLT2 inhibitors |
| sICAM-1 | Soluble intercellular adhesion molecule-1 |
| Smad | Mothers against decapentaplegic homolog |
| SOCS | Suppressors of cytokine signaling |
| SREBP-1 | Sterol regulatory element binding transcription factor 1 |
| STAT | Signal Transducer and Activator of Transcription |
| sTWEAK | Soluble TNF-related weak inducer of apoptosis |
| STZ | Streptozotocin |
| T1DM | Type 1 and type 2 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| TBHQ | Tert-butylhydroquinone |
| TGF-β | Transforming growth factor-β |
| Th1 | T helper cell type 1 |
| Th17 | T helper cell type 17 |
| Th2 | T helper cell type 2 |
| TLRs | Toll-like receptors |
| TNF-α | Tumor necrosis factor-α |
| TNFR1 | Tumor necrosis factor receptor 1 |
| TNFR2 | Tumor necrosis factor receptor 2 |
| Tregs | Regulatory T cells |
| TYK2 | Tyrosine kinase 2 |
| UACR | Urine albumin to creatinine ratio |
| VAP-1 | Vascular adhesion protein-1 |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| VEGF | Vascular endothelial growth factor |
| VEGFR2 | Vascular endothelial growth factor receptor 2 |
| ZSF1 | Zucker Diabetic Fatty 1 |
| α-SMA | α-smooth muscle actin |